Infinium Pharmachem IPO Particulars & Guidance at Chanakyanipothi.com, the Oldest & the most Trusted Investment Website in India for coming up IPOs. Operational since 8th December 1999, this is the Only Investment Platform in India, which has successfully completed 23 Years.
Infinium Pharmachem IPO Listing:
The scrip listed at Rs. 141.50 as compared to issue price of Rs. 135.
Infinium Pharmachem IPO Guidance:
The company is in the manufacturing of Pharma intermediates and API, Huge potential, The profits have increased during last 2 years, Not much fancy in the grey market.
Infinium Pharmachem IPO Grey Market updates
GMP prior to listing
GMP: Rs.2
Infinium Pharmachem IPO Subscription Status
On 5 April 2023 @ 5.00 (Closed)
NII: 870000 Shares, 1.80T
RII: 870000 Shares,1.86T
Total: 1740000 Shares 1.84T
Infinium Pharmachem IPO Particulars & Guidance: About the business
The Company is dealing specifically and mainly in manufacturing and supplying of Iodine Derivatives, Pharma Intermediates and Active Pharmaceutical Ingredients (APIs). The Company has its manufacturing plant at Plot No. 37, 38, 39, 29, 30, 01 GIDC Sojitra, Dist. Anand – 387240, Gujarat, India since
inception, spread across 6204.53 Sq. Mtrs. of land.
The Company undertakes Contract Research and Manufacturing Services (CRAMS) to provide customized and fully confidential solutions to its clients.
Today, the Company’s manufacturing capabilities and technical expertise have efficiently catered numerous industries such as Pharmaceutical & Biotech, Specialty & Performance Chemicals, Agrochemicals, Human Health, Animal Health, Cosmetics, Sanitation, Electrical, Electronics and much more. The Company have auditable manufacturing facility and it has been audited by various well known pharma giants worldwide.
The Company currently provides the widest range of Iodine derivatives in the market, with more than 250+ intermediates and 15+ APIs. All its products are developed to meet challenging demands, superior quality, performance and various other commercial requirements across industries.
For more information about the company, Click www.infiniumpharmachem.com
Infinium Pharmachem IPO Details | |
IPO opens on | 31 March 2023 |
IPO closes on | 05 April 2023 |
Issue Type | Book Built Issue IPO |
Issue Size | 1875000 Sh /Rs 25.31 Cr |
* Fresh Issue | 1875000 Sh /Rs 25.31 Cr |
* Offer for Sale | – Sh /Rs – Cr |
Face Value per share: | Rs. 10 |
Price Band | Rs.135 |
Employee discount | Rs. 0 per share |
Retail Lot Size | 1000Shares |
Listing will at | NSE Sme |
Shares offered to | ||
Shares | Rs. (Cr) | |
– | ||
NII (50 %) | – | – |
RII (50 %) | – | – |
Total Shares | 1781000 | 24.04 |
Retail portion will be oversubscribed by | 891 | |
Forms | ||
How much Shares to Apply? | ||
Min Retail Application | 1000 Sh | Rs. 135000 |
Min HNI Application | 2000 Sh | Rs. 270000 |
Promoters of the IPO
Mr. Sanjaykumar Vithalbhai Patel, Mr. Pravin Bhadabhai Madhani & MR. Mitesh Lavjibhai Chikhaliya
Objects of the IPO:
The Company proposes to utilize the Net Proceeds from the Issue towards
1. Marketing and branding expenses (including registration in reach – Europe, and other marketing expenses).
2. Repayment of some of the existing loans and expansion of units.
3. To meet incremental working capital requirements.
IPO Tentative timetable | |
IPO opens on | 31 March 2023 |
IPO Closes on | 05 April 2023 |
IPO Allotment on | 11 April 2023 |
Unblocking of ASBA | 12 April 2023 |
Credit of Shares | 13 April 2023 |
Listing on | 17 April 2023 |
Registered Office of the Company |
38 G.I.D.C Sojitra, Taluka – Sojitra, Dist. – Anand, Gujarat – 387240, India |
IPO Lead Managers |
SWASTIKA INVESTMART Ltd |
Registrar to the IPO |
BIGSHARE SERVICES Pvt. Ltd. |
IPO Financial & Analytical Ratios | ||||
Year | Total Income | Net Profit | EPS | RoNW |
Rs.in Cr | Rs.in Cr | Rs. | % | |
2019-20 | 39.42 | 0.87 | – | 21.99 |
2020-21 | 71.15 | 2.73 | – | 38.80 |
2021-22 | 100.05 | 6.69 | 11.24 | 46.61 |
Book Value of the Share on | 31.12.2022 | Rs. | ||
Book Value of the Share | after the IPO | Rs.68.82 | ||
Offer Price | Rs. 135 |
Ratio Analysis | |
Upper Price/last EPS | 12.01 |
Upper price/BV Ratio | – |
Upper price/BV after IPO | 1.99 |
–
Infinium Pharmachem IPO Particulars & Guidance
Peer Comparison:
As on date of DRHP | FV | Income | PE |
Rs. | in Cr | Ratio of | |
The IPO Company | 10 | 100.05 | 12.01 |
Samrat Pharmachem | 10 | 12.99 | |
# This is only coverage of News related to Grey Market. We do not deal in grey market premium, nor we recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.
>>Go to Mainboard IPOs Section: Click
>>Get Good Staff or Job, Click: Staffavailable.com
>>Interested in Used Automobiles or vintage cars? Click: BigGaddi.com
>>Get solid Guidance on Mutual fund Investments, Click: ChanakyaMFGuidance.com
>>Study Stock Research Reports, Click: AnalysisLibrary.com
>>Interested in Crossword Puzzles? Click: Magajmari.com
Company’s revenue and profits are on rising trend. Valuation is reasonable.
Seems investible